CSPC Pharma Limited submitted the latest monthly securities variation report on October 31, 2024, showing that the company conducted a share repurchase and cancellation in October 2024, resulting in a decrease in the number of issued shares. According to the report, the total number of issued shares of CSPC Pharma at the end of October was 11,695,881,732 shares, a decrease of 49,590,000 shares from the previous month. The share movements were made based on the share options plan effective on December 9, 2015, and approved at the shareholders' meeting on May 28, 2024. The specific date of the share repurchase and cancellation was October 15, 2024. Additionally, the report mentioned that the number of share options held at the end of this month under the share options plan was 30,500,000 shares, unchanged from the previous month, and new shares may be issued in the future when the plan is exercised. The report was submitted by Company Secretary Luo Tai'an on November 1, 2024.

CSPC Pharma Limited submitted the latest monthly securities variation report on October 31, 2024, showing that the company conducted a share repurchase and cancellation in October 2024, resulting in a decrease in the number of issued shares. According to the report, the total number of issued shares of CSPC Pharma at the end of October was 11,695,881,732 shares, a decrease of 49,590,000 shares from the previous month. The share movements were made based on the share options plan effective on December 9, 2015, and approved at the shareholders' meeting on May 28, 2024. The specific date of the share repurchase and cancellation was October 15, 2024. Additionally, the report mentioned that the number of share options held at the end of this month under the share options plan was 30,500,000 shares, unchanged from the previous month, and new shares may be issued in the future when the plan is exercised. The report was submitted by Company Secretary Luo Tai'an on November 1, 2024.